Q3 Earnings Results Cause Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Stock To Fall

Boston, MA 11/01/2013 (wallstreetpr) – Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was negatively impacted with the posting of the third quarter earnings results that failed to meet analysts and investors expectations. The abrupt departure of its Chief Executive Officer Jeremy Levin also continues to disrupt the fortunes of the drug maker. Teva’s Depositary receipts fell by […]

Chromadex Gets A Supplemental Boost From Stock Guru (CDXC)

ChromaDex (OTC: CDXC), a natural products company, has gotten the attention of at least one world-class investor. Dr. Phillip Frost known for his sale of drug maker IVAX to TEVA (NYSE: TEVA) for $7.6 billion in 2005 has been accumulating shares of ChromaDex according to a news story released this afternoon. In June, Frost added […]